WRYJBBQRDNBGAQ-SOLBZPMBSA-N
C26H31F3N6O5 — CID 121352229
Data last refreshed: (MolForge compound catalog, from PubChem)
About WRYJBBQRDNBGAQ-SOLBZPMBSA-N
WRYJBBQRDNBGAQ-SOLBZPMBSA-N (PubChem CID 121352229) has the molecular formula C26H31F3N6O5 and a molecular weight of 564.57 g/mol. Its IUPAC name is (9S)-8-N-[5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-N-[(2R)-1,1,1-trifluoropropan-2-yl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-5,8-dicarboxamide.
Molecular Properties
| Compound Name | WRYJBBQRDNBGAQ-SOLBZPMBSA-N |
|---|---|
| PubChem CID | 121352229 |
| Molecular Formula | C26H31F3N6O5 |
| Molecular Weight | 564.57 g/mol |
| Exact Mass | 564.23 |
| IUPAC Name | (9S)-8-N-[5-[[(4R)-2,2-dimethyl-1,3-dioxolan-4-yl]methoxy]-2-pyridinyl]-3-methyl-5-N-[(2R)-1,1,1-trifluoropropan-2-yl]-1,6,8-triazatricyclo[7.2.1.02,7]dodeca-2(7),3,5-triene-5,8-dicarboxamide |
| SMILES | Cc1cc(C(=O)N[C@H](C)C(F)(F)F)nc2c1N1CC[C@@H](C1)N2C(=O)Nc1ccc(OC[C@@H]2COC(C)(C)O2)cn1 |
| InChI | InChI=1S/C26H31F3N6O5/c1-14-9-19(23(36)31-15(2)26(27,28)29)32-22-21(14)34-8-7-16(11-34)35(22)24(37)33-20-6-5-17(10-30-20)38-12-18-13-39-25(3,4)40-18/h5-6,9-10,15-16,18H,7-8,11-13H2,1-4H3,(H,31,36)(H,30,33,37)/t15-,16+,18-/m1/s1 |
| InChIKey | WRYJBBQRDNBGAQ-SOLBZPMBSA-N |
| XLogP | 3.63 |
| TPSA | 118.15 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 564.57 |
| LogP ≤ 5 | 3.63 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 121352229 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.